In the second fiscal report after Danish Widex and EQT-owned Sivantos merged to form the world's third-largest hearing aid company WS Audiology, the firm now has another billion-kroner loss riddled with negative double-digit growth rates.
On the bottom line WS Audiology suffered through a EUR 243 (USD 293.8m) net deficit, which was only marginally better than the year before, when the company's EUR 285m deficit was explained through one-time expenses relating to the EUR 211.5m merger.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Manager of QA, BHS Logistics 
Chief Business Officer 
LIMS Super User for Operations at ALK 
Pharmacovigliance (Associate) Director or Senior Specialist 
eTMF Manager 
Scientist Radiochemistry 
Ambitious Business Relationship Manager for the Danish Medicines Agency 
Nordic Key Account Manager, Hollister & Dansac 
Senior CMC Regulatory Manager 
Senior Clinical Research Scientist 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Vice President, Medical Affairs 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Clinical Project Lead